Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection
May 28, 2021 08:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), today announced that the company has received a Complete Response Letter (CRL) from the U.S. Food &...
Eton Pharmaceuticals Reports Record Revenue and Earnings
May 13, 2021 16:05 ET
|
Eton Pharmaceuticals
First quarter 2021 revenue of $11.9 millionFirst quarter 2021 operating earnings of $5.4 million; EPS of $0.19Eton now has three commercial, revenue-generating products DEER PARK, Ill., May 13, 2021...
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
May 04, 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
March 17, 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
March 16, 2021 16:02 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021
March 04, 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
February 16, 2021 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
February 08, 2021 08:00 ET
|
Eton Pharmaceuticals
Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company...
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
January 14, 2021 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
December 17, 2020 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...